Cannabinoids in bipolar affective disorder: a review and discussion of their therapeutic potential
Ashton CH, Moore PB, Gallagher P, Young AH.
Department of Psychiatry,
University of Newcastle upon Tyne,
Royal Victoria Infirmary,
Newcastle upon Tyne, UK.
J Psychopharmacol. 2005 Sep;19(3):293-300
ABSTRACTBipolar affective disorder is often poorly controlled by prescribed drugs. Cannabis use is common in patients with this disorder and anecdotal reports suggest that some patients take it to alleviate symptoms of both mania and depression. We undertook a literature review of cannabis use by patients with bipolar disorder and of the neuropharmacological properties of cannabinoids suggesting possible therapeutic effects in this condition. No systematic studies of cannabinoids in bipolar disorder were found to exist, although some patients claim that cannabis relieves symptoms of mania and/or depression. The cannabinoids Delta(9)-tetrahydrocannabinol (THC) and cannabidiol (CBD) may exert sedative, hypnotic, anxiolytic, antidepressant, antipsychotic and anticonvulsant effects. Pure synthetic cannabinoids, such as dronabinol and nabilone and specific plant extracts containing THC, CBD, or amixture of the two in known concentrations, are available and can be delivered sublingually. Controlled trials of these cannabinoids as adjunctive medication in bipolar disorder are now indicated.THC
Just say know
Stoned as a newt?
The nectar of delight
Cannabis Abuse Disorder
Cannabis and schizophrenia
Cannabis, cannabinoids and the brain
01 02 03 04 05 06 07 08 09 10 11 12 13 14 15
The Hedonistic Imperative
MDMA: Utopian Pharmacology
When Is It Best To Take Crack Cocaine?
The Good Drug Guide
The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family